注射吸毒者全关节置换术后假体周围感染的发生率与结局
该回顾性匹配队列研究比较有与无注射吸毒史的全关节置换患者,发现注射吸毒者假体周围感染风险约为对照组的9倍,活动性吸毒者感染率更高,且感染后治疗失败率高。作者认为注射吸毒是全关节置换术后假体周围感染的显著危险因素,未来可研究多学科支持团队协助戒毒能否改善结局。
要点
- 注射吸毒者全关节置换术后假体周围感染风险约为匹配对照组的9倍(OR 9.605,95%CI 2.781-33.175,P<.001)。
- 末次吸毒在初次全关节置换前6个月内的活动性吸毒者17例中10例发生假体周围感染,非活动性吸毒者41例中7例发生感染。
- 注射吸毒者发生假体周围感染后17例中15例治疗失败,无吸毒史感染患者8例中5例治疗失败。
核心结论
- 注射吸毒是全关节置换术后假体周围感染的显著危险因素。
- 未来研究多学科支持团队协助停止注射吸毒并提供社会支持,可能改善这一脆弱人群的结局并降低发病率。
研究设计与样本
- 回顾性匹配队列研究,按1:4匹配有与无注射吸毒史接受全关节置换的患者。
- 采用多因素logistic回归比较人口学、手术和结局变量以确定假体周围感染预测因素。
- 构建Kaplan-Meier分析比较注射吸毒者与匹配队列之间无假体周围感染或未行关节取出术的生存差异。
主要发现
- 注射吸毒者假体周围感染风险为匹配队列的9倍(OR 9.605,95%CI 2.781-33.175,P<.001)。
- 末次吸毒在初次全关节置换前6个月内的活动性吸毒者17例中10例发生假体周围感染,非活动性吸毒者41例中7例发生假体周围感染。
- 注射吸毒者发生假体周围感染后17例中15例治疗失败,无注射吸毒史患者发生假体周围感染后8例中5例治疗失败。
关键数值与推荐
- 注射吸毒者假体周围感染风险升高(OR 9.605,95%CI 2.781-33.175,P<.001)。
- 活动性吸毒(末次吸毒在初次全关节置换前6个月内)者17例中10例发生假体周围感染。
- 非活动性吸毒者41例中7例发生假体周围感染。
- 注射吸毒者发生假体周围感染后17例中15例治疗失败。
- 无注射吸毒史患者发生假体周围感染后8例中5例治疗失败。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The risk of periprosthetic joint infection (PJI) is higher in persons who inject drugs (PWID) after total joint arthroplasty (TJA), though reported rates vary widely. This study was designed to assess outcomes of TJA in PWID and to describe factors associated with improved PJI outcomes among PWID. METHODS: A retrospective matched cohort study was performed using a 1:4 match among those with and those without a history of injection drug use (IDU) undergoing TJA. Demographic, surgical, and outcome variables were compared in multivariate logistic regressions to determine PJI predictors. Kaplan-Meier analyses were constructed to characterize the difference in survival of patients who did not have PJI or undergo joint explantation between PWID and the matching cohort. RESULTS: PWID had a 9-fold increased risk of PJI compared to the matched cohort (odds ratio 9.605, 95% CI 2.781-33.175, P < .001). Ten of 17 PWID whose last use was within 6 months (active use) of primary TJA had a PJI, while 7 of 41 PWID who did not have active use developed a PJI. Of PWID with PJI, treatment failure was seen in 15 of 17, while in patients who did not have an IDU history, 5 of 8 with PJI had treatment failure. CONCLUSION: IDU is a significant risk factor for PJI following TJA. Future work investigating the effect of a multidisciplinary support team to assist in cessation of IDU and to provide social support may improve outcomes and reduce morbidity in this vulnerable population.
引用
- Humphrey TJ, Tatara AM, Bedair HS, et al. Rates and Outcomes of Periprosthetic Joint Infection in Persons Who Inject Drugs. J Arthroplasty. 2022. PMID: 35931269. doi:10.1016/j.arth.2022.07.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。